Skip to main content
. Author manuscript; available in PMC: 2019 Dec 1.
Published in final edited form as: Injury. 2018 Sep 20;49(12):2186–2192. doi: 10.1016/j.injury.2018.09.035

Table 1.

Lower limit of detection (LLD) for substances screened in post-mortem whole blood specimens followed by confirmatory lower limit of quantification (LLQ).

Screening cut offs Confirmatory cut offs
Drug Class Screening LLD
(ng/ml)
Compounds Confirmatory LLQ
(ng/ml)
Alcohola 0.01% (w/v)
Ethanola 0.02% (w/v)
Amphetamines 50
d-Amphetamine 20
d-Methamphetamine 50
MDMA 50
MDA 20
Phencyclidine (PCP) 10
Phencyclidine 10
Cocaine 20
Cocaine 50
Benzoylecognine 20
Cocaethylene 20
Cannabinoids (THC)b 5
THC-OH 1
Cannabidiol 1
THC-COOH 5
Cannabinol 1
THC 1
Benzodiazepines (Temazepam)b 20
Alprazolam 5
Diazepam 5
Midazolam 5
Nordiazepam 5
Desalkyflurezepam 5
Chlordiazepoxide 0.05
Temazepam 5
Barbiturates (Secobarbital) 20
Phenobarbital 50
Opiates and Opioids 20
Methadone 50
Morphine 50
Fentanyl 2.5
Oxycodone 50
Hydrocodone 10
a

Ethanol screened and confirmed by Headspace GC-FID. Values are in percent weight/volume

b

LC-MS/MS technique applied for confirmation. All other confirmatory procedures were done by GC-MS, unless otherwise noted.